LGND
Ligand Pharmaceuticals IncorporatedNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$4.09B
P/E Ratio
33.46
EPS
$6.13
Beta
1.00
52W High
$227.92
52W Low
$97.48
50-Day MA
$198.11
200-Day MA
$177.02
Dividend Yield
—
Profit Margin
46.40%
Forward P/E
23.47
PEG Ratio
1.53
About Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies discover and develop drugs globally. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $268.09M |
| Gross Profit (TTM) | $172.36M |
| EBITDA | $80.97M |
| Operating Margin | 33.60% |
| Return on Equity | 13.50% |
| Return on Assets | 2.36% |
| Revenue/Share (TTM) | $13.86 |
| Book Value | $51.44 |
| Price-to-Book | 3.92 |
| Price-to-Sales (TTM) | 15.26 |
| EV/Revenue | 13.73 |
| EV/EBITDA | 18.65 |
| Quarterly Earnings Growth (YoY) | 103.20% |
| Quarterly Revenue Growth (YoY) | 39.40% |
| Shares Outstanding | $19.94M |
| Float | $19.47M |
| % Insiders | 2.46% |
| % Institutions | 105.62% |
Analyst Ratings
Consensus ($245.10 target)
2
Strong Buy6
BuyData last updated: 4/8/2026